Packaging and Delivery of Asthma Therapeutics
Open Access
- 31 December 2021
- journal article
- review article
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (1) , 92
Abstract
Asthma is a life-altering, chronic disease of heterogenous origin that features a complex interplay of immune and environmental signaling. Although very little progress has been made in prevention, diverse types of medications and delivery systems, including nanoscale systems, have been or are currently being developed to control airway inflammation and prevent exacerbations and fibrosis. These medications are delivered through mechanical methods, with various inhalers (with benefits and drawbacks) existing, and new types offering some variety in delivery. Of particular interest is the progress being made in nanosized materials for efficient penetration into the epithelial mucus layer and delivery into the deepest parts of the lungs. Liposomes, nanoparticles, and extracellular vesicles, both natural and synthetic, have been explored in animal models of asthma and have produced promising results. This review will summarize and synthesize the latest developments in both macro-(inhaler) and micro-sized delivery systems for the purpose of treating asthma patients.Keywords
This publication has 173 references indexed in Scilit:
- Effects of high altitude and cold air exposure on airway inflammation in patients with asthmaThorax, 2013
- Liposomes prolong the therapeutic effect of anti-asthmatic medication via pulmonary deliveryInternational Journal of Nanomedicine, 2012
- Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulationBMC Pulmonary Medicine, 2011
- Thymic Stromal Lymphopoietin Gene Promoter Polymorphisms Are Associated with Susceptibility to Bronchial AsthmaAmerican Journal of Respiratory Cell and Molecular Biology, 2011
- New cytochrome P450 mechanisms: implications for understanding molecular basis for drug toxicity at the level of the cytochromeExpert Opinion on Drug Metabolism & Toxicology, 2009
- Histone deacetylase-2 and airway diseaseTherapeutic Advances in Respiratory Disease, 2009
- Remodeling in AsthmaProceedings of the American Thoracic Society, 2009
- Transdermal drug deliveryNature Biotechnology, 2008
- Evaluation of Cetirizine in Patients with Allergic Rhinitis and Perennial AsthmaAnnals of Allergy, Asthma & Immunology, 1996
- TerfenadineDrugs, 1990